Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C003585 |
22-hydroxycholesterol |
22-hydroxycholesterol binds to and results in increased activity of NR1H3 protein | affects binding|increases activity | 12932788
|
C003585 |
22-hydroxycholesterol |
[alitretinoin co-treated with 22-hydroxycholesterol] affects the localization of NR1H3 protein | affects cotreatment|affects localization | 16888799
|
C003585 |
22-hydroxycholesterol |
22-hydroxycholesterol results in increased activity of NR1H3 protein | increases activity | 9603267
|
C028358 |
24,25-epoxycholesterol |
NR1H3 protein promotes the reaction [24,25-epoxycholesterol results in increased abundance of Lipids] | increases abundance|increases reaction | 20079722
|
C028358 |
24,25-epoxycholesterol |
24,25-epoxycholesterol binds to and affects the activity of NR1H3 protein | affects activity|affects binding | 11290837
|
C044563 |
24-hydroxycholesterol |
24-hydroxycholesterol binds to and affects the activity of NR1H3 protein | affects activity|affects binding | 11290837
|
C007997 |
25-hydroxycholesterol |
25-hydroxycholesterol results in increased activity of NR1H3 protein | increases activity | 9603267
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of NR1H3 mRNA | affects expression | 21346803
|
C029435 |
3-hydroxy-5-cholestenoic acid |
3-hydroxy-5-cholestenoic acid affects the reaction [NR1H3 protein binds to NCOA2 protein] | affects binding|affects reaction | 11089551
|
C029435 |
3-hydroxy-5-cholestenoic acid |
3-hydroxy-5-cholestenoic acid binds to and results in increased activity of NR1H3 protein | affects binding|increases activity | 11089551
|
C100324 |
4,4-dimethylcholesta-8,14,24-trienol |
4,4-dimethylcholesta-8,14,24-trienol results in increased activity of NR1H3 protein | increases activity | 9603267
|
C046938 |
9,11-linoleic acid |
9,11-linoleic acid results in increased expression of NR1H3 mRNA | increases expression | 15778275
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of NR1H3 protein | affects expression | 20106945
|
C103303 |
alitretinoin |
[alitretinoin co-treated with 22-hydroxycholesterol] affects the localization of NR1H3 protein | affects cotreatment|affects localization | 16888799
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NR1H3 mRNA | affects expression | 16483693
|
C432165 |
anthra(1,9-cd)pyrazol-6(2H)-one |
anthra(1,9-cd)pyrazol-6(2H)-one results in increased expression of NR1H3 mRNA | increases expression | 19883121
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased activity of NR1H3 protein | decreases activity | 20339114
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of NR1H3 mRNA | decreases expression | 20064835
|
D001647 |
Bile Acids and Salts |
NR1H3 protein affects the chemical synthesis of Bile Acids and Salts | affects chemical synthesis | 15725701
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of NR1H3 mRNA | increases expression | 14967926
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of NR1H3 mRNA] | decreases expression|decreases reaction | 17070507
|
D002784 |
Cholesterol |
NR1H3 protein affects the metabolism of Cholesterol | affects metabolic processing | 15725701
|
D002784 |
Cholesterol |
NR1H3 protein affects the transport of Cholesterol | affects transport | 15725701
|
D002791 |
Cholesterol, Dietary |
[Cholesterol, Dietary co-treated with Cholic Acid] results in increased activity of NR1H3 protein | affects cotreatment|increases activity | 14684380
|
D002791 |
Cholesterol, Dietary |
Cholesterol, Dietary results in increased activity of NR1H3 protein | increases activity | 14684380
|
D019826 |
Cholic Acid |
[Cholesterol, Dietary co-treated with Cholic Acid] results in increased activity of NR1H3 protein | affects cotreatment|increases activity | 14684380
|
C019304 |
ciprofibrate |
ciprofibrate results in decreased expression of NR1H3 mRNA | decreases expression | 12771043
|
C503589 |
cis-9, trans-11-conjugated linoleic acid |
cis-9, trans-11-conjugated linoleic acid affects the expression of NR1H3 mRNA | affects expression | 17327424
|
D002994 |
Clofibrate |
Clofibrate results in increased expression of NR1H3 mRNA | increases expression | 14690017
|
D002994 |
Clofibrate |
Ketoconazole inhibits the reaction [Clofibrate results in increased expression of NR1H3 mRNA] | decreases reaction|increases expression | 14690017
|
D003474 |
Curcumin |
Curcumin results in increased expression of NR1H3 mRNA | increases expression | 16713233
|
D003513 |
Cycloheximide |
Cycloheximide results in increased expression of NR1H3 mRNA | increases expression | 19684285
|
D003513 |
Cycloheximide |
[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of NR1H3 mRNA | affects cotreatment|increases expression | 19684285
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of NR1H3 mRNA | decreases expression | 20106945
|
D003907 |
Dexamethasone |
Dexamethasone results in increased expression of NR1H3 mRNA | increases expression | 19022236
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of NR1H3 mRNA | increases expression | 18457598 17932310
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of NR1H3 mRNA | decreases expression | 12771043
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of NR1H3 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NR1H3 mRNA | affects cotreatment|increases expression | 17942748
|
D005231 |
Fatty Acids, Unsaturated |
Fatty Acids, Unsaturated binds to and results in decreased activity of NR1H3 protein | affects binding|decreases activity | 12970175
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of NR1H3 mRNA | increases expression | 18035473
|
C504517 |
GSK 3987 |
GSK 3987 binds to and results in increased activity of NR1H3 protein | affects binding|increases activity | 16107141
|
C504517 |
GSK 3987 |
GSK 3987 binds to NR1H3 protein | affects binding | 16107141
|
C473027 |
GW 3965 |
GW 3965 binds to and results in increased activity of NR1H3 protein | affects binding|increases activity | 12932788
|
C473027 |
GW 3965 |
GW 3965 results in increased expression of NR1H3 mRNA | increases expression | 17449538
|
C473027 |
GW 3965 |
GW 3965 binds to and results in increased activity of NR1H3 protein | affects binding|increases activity | 15633131
|
C473027 |
GW 3965 |
GW 3965 results in increased activity of NR1H3 protein | increases activity | 17420776
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of NR1H3 mRNA | affects cotreatment|increases expression | 17183730
|
C051140 |
iron(II)-ascorbic acid complex |
Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of NR1H3 mRNA] | decreases expression|decreases reaction | 17070507
|
C051140 |
iron(II)-ascorbic acid complex |
iron(II)-ascorbic acid complex results in decreased expression of NR1H3 mRNA | decreases expression | 17070507
|
D007654 |
Ketoconazole |
Ketoconazole inhibits the reaction [Clofibrate results in increased expression of NR1H3 mRNA] | decreases reaction|increases expression | 14690017
|
D008055 |
Lipids |
NR1H3 protein promotes the reaction [24,25-epoxycholesterol results in increased abundance of Lipids] | increases abundance|increases reaction | 20079722
|
D008055 |
Lipids |
NR1H3 protein promotes the reaction [paxilline results in increased abundance of Lipids] | increases abundance|increases reaction | 20079722
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of NR1H3 mRNA | decreases expression | 16847310
|
C048220 |
paxilline |
NR1H3 protein promotes the reaction [paxilline results in increased abundance of Lipids] | increases abundance|increases reaction | 20079722
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in decreased expression of NR1H3 mRNA | decreases expression | 17681415
|
C059514 |
resveratrol |
resveratrol results in increased expression of NR1H3 mRNA | increases expression | 16901463
|
C059514 |
resveratrol |
resveratrol results in increased expression of NR1H3 protein | increases expression | 16901463
|
C093642 |
SB 203580 |
SB 203580 results in increased expression of NR1H3 mRNA | increases expression | 19883121
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of NR1H3 mRNA | decreases expression | 19822182
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of NR1H3 mRNA | affects cotreatment|increases expression | 19684285
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of NR1H3 mRNA | increases expression | 19684285
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NR1H3 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of NR1H3 mRNA | increases expression | 18796159
|
C423915 |
TO-901317 |
TO-901317 binds to and results in increased activity of NR1H3 protein | affects binding|increases activity | 12932788 12970175
|
C423915 |
TO-901317 |
TO-901317 promotes the reaction [[NR1H3 protein binds to NR1H2 protein] which binds to SREBF1 promoter] | affects binding|increases reaction | 15548517
|
C423915 |
TO-901317 |
TO-901317 results in increased expression of NR1H3 mRNA | increases expression | 17449538
|
C423915 |
TO-901317 |
TO-901317 binds to and results in increased activity of NR1H3 protein | affects binding|increases activity | 19509184 17088262
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of NR1H3 mRNA | increases expression | 16054129
|
C113580 |
U 0126 |
U 0126 inhibits the reaction [TNF protein results in decreased expression of NR1H3 mRNA] | decreases expression|decreases reaction | 19883121
|
C113580 |
U 0126 |
U 0126 results in increased expression of NR1H3 mRNA | increases expression | 19883121
|
D014501 |
Uranium |
Uranium results in increased expression of NR1H3 mRNA | increases expression | 16231126
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of NR1H3 mRNA | affects cotreatment|increases expression | 17183730
|
D015054 |
Zymosan |
Zymosan results in decreased expression of NR1H3 mRNA | decreases expression | 16847310
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
6.54 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
6.54 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.45 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.02 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.39 | 17505938 |
MESH:D000168 |
Acrocephalosyndactylia |
|
U 0126 |
4.95 | 17694057 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.38 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
3.54 | 11850527 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
6.04 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
6.04 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
6.04 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
9.27 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
9.27 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
resveratrol |
9.27 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
8.27 | 17162532 19061943 18056438 16434500 19052882 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.27 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.15 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.35 | 16712894 17306315 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.53 | 17887948 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.18 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
24-hydroxycholesterol |
8.35 | 14523054 |
MESH:D000544 |
Alzheimer Disease |
|
Cholesterol, Dietary |
8.35 | 20157255 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
8.35 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
8.35 | 16162502 16183991 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.68 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.44 | 11748828 |
MESH:D000740 |
Anemia |
|
Zymosan |
7.44 | 18664788 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.14 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.55 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
9,11-linoleic acid |
20.21 | 15778275 |
MESH:D001161 |
Arteriosclerosis |
|
Cholesterol, Dietary |
20.21 | 15552841 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
20.21 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
20.21 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
19.34 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
19.34 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
19.34 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
19.34 | 16412693 |
MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
19.34 | 15188379 15142272 15944321 17659584 16872482 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
4.21 | 16807698 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.21 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.16 | 16456186 |
MESH:D050197 |
Atherosclerosis |
|
Cholesterol |
9.27 | 16632123 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
9.27 | 18704882 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
9.27 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.08 | 18940202 15238991 17157402 18558336 17507914 20603192 17688650 18177632 19460635 18775368 19232924 18985861 18396377 16609825 18316065 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
3.97 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.89 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.78 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
18.05 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Clofibrate |
18.05 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
18.05 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
18.05 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.24 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
6.82 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
6.82 | 8888407 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.38 | 11985600 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
8.54 | 16770732 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
8.54 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
3.47 | 17596214 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
5.13 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
5.13 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
5.13 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
5.13 | 18593918 18462866 19250217 16243823 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
5.13 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
5.13 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
5.13 | 16393696 17534123 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
5.13 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
5.13 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.05 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.83 | 11589617 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
6.86 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
6.86 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.61 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
14.90 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
14.90 | 12619106 12907637 21507988 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
14.90 | 19418558 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
14.90 | 16217749 15553829 14691202 11135700 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
14.90 | 16569478 16328049 18056438 19519916 10737359 3581430 19383236 19701751 20524982 20514400 16779866 18506893 18494052 18393292 17055752 20727157 19208518 3084413 20007298 19394651 20432363 16878318 18971187 19919837 16830150 18788625 16540662 18785209 19822196 18210153 21159647 19335982 20101231 20084675 20512989 19052882 17162532 17173139 16935385 16288022 10672840 17761372 16681979 19539802 19418558 17978847 18978308 20935162 16698587 16502159 20214788 16807293 11831363 19171122 18665156 17138121 18691550 17428255 19107877 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
14.90 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
14.90 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
14.90 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.45 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.05 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
2.77 | 18414057 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.33 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.65 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
12.31 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
12.31 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
12.31 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
12.31 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
12.31 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.05 | 18850075 18670907 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.10 | 15458977 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.76 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
17.06 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Clofibrate |
17.06 | 1399818 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
17.06 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
17.06 | 7505956 21159647 17174075 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
17.06 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.05 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.49 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
7.81 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
7.81 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
6.43 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
6.43 | 15861022 16919318 17110522 17681005 11677210 16105132 17333356 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.61 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
4.92 | 16354765 8697196 15340226 12621046 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
4.92 | 9407595 |
MESH:D003092 |
Colitis |
|
Curcumin |
13.07 | 16804969 18200517 16782535 |
MESH:D003092 |
Colitis |
|
resveratrol |
13.07 | 16474422 |
MESH:D003092 |
Colitis |
|
Tretinoin |
13.07 | 17035595 |
MESH:D003103 |
Coloboma |
|
Curcumin |
4.07 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
5.20 | 19359593 16340194 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
5.20 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
5.20 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.47 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.47 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.61 | 17141729 14669216 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.37 | 18497527 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.39 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.67 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
6.47 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
6.47 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
6.47 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
6.47 | 9142499 16925845 14991402 10589399 9664655 9224671 9211117 17551590 8800419 9125849 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
6.47 | 8888407 17688650 16575769 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.49 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.60 | 15213294 |
MESH:D003715 |
Dengue |
|
24-hydroxycholesterol |
5.67 | 19427377 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
2.91 | 12438553 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.33 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
6.17 | 18403477 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.17 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.17 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
7.73 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
7.73 | 16286809 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.20 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
9.97 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
9.97 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ketoconazole |
9.97 | 18289764 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.97 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
9.97 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.36 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
3.54 | 17351913 |
MESH:D050171 |
Dyslipidemias |
|
Clofibrate |
7.50 | 16707586 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
7.50 | 18367378 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.55 | 1851702 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
3.95 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
16.64 | 19703484 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
16.64 | 17259670 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
16.64 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
16.64 | 12711302 11000095 |
MESH:D004487 |
Edema |
|
Zymosan |
16.64 | 7907874 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.12 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.12 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
24-hydroxycholesterol |
12.70 | 17410599 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
12.70 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
12.70 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
2.75 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.56 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
3.86 | 15821434 17637181 15328337 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.32 | 17923197 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.63 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.37 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.64 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.14 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
3.77 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.53 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.57 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
3.88 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
3.88 | 16530937 |
MESH:D004942 |
Esophagitis, Peptic |
|
Bile Acids and Salts |
6.00 | 11346197 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.48 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.48 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
34.90 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Clofibrate |
34.90 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
34.90 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
34.90 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
34.90 | 17967931 18296743 19551842 19004024 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
34.90 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
34.90 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
34.90 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.93 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.34 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.62 | 8888407 18558336 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.55 | 9205823 11852909 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
22.20 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
22.20 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
22.20 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
22.20 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
22.20 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.75 | 16904648 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.17 | 18462866 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.14 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.68 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
6.08 | 17596214 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.08 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.05 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
6.64 | 18829502 18462866 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
6.64 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.61 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
9.31 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
9.31 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
9.31 | 14991402 9664655 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.88 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
3.91 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.85 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Zymosan |
4.19 | 19110552 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
6.94 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
6.94 | 12621046 16120746 15340226 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.51 | 17701891 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.86 | 7520565 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.65 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.71 | 12676792 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.33 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.50 | 15340226 16959395 8697196 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
6.63 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
6.63 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol |
23.49 | 16933029 |
MESH:D006937 |
Hypercholesterolemia |
|
Cholesterol, Dietary |
23.49 | 10876104 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
23.49 | 18704882 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
23.49 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
23.49 | 17188708 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.04 | 16778211 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
7.65 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
7.65 | 16873680 |
MESH:D006951 |
Hyperlipoproteinemias |
|
Fatty Acids, Unsaturated |
5.71 | 18435438 |
MESH:D006967 |
Hypersensitivity |
|
Butylated Hydroxytoluene |
4.04 | 17604070 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.22 | 10903974 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
7.22 | 17042910 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.22 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.10 | 16612254 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.83 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.28 | 16569931 16945680 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.12 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.97 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
5.41 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
5.41 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Curcumin |
31.14 | 16956363 18403477 17151092 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
31.14 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
31.14 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
31.14 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
31.14 | 17296493 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
31.14 | 9205823 12878042 17255318 17237260 17963957 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
31.14 | 12083418 |
MESH:D007249 |
Inflammation |
|
resveratrol |
31.14 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
31.14 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Zymosan |
31.14 | 8014878 11289658 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
2.97 | 18200517 18596194 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.00 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
6.27 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
6.27 | 18457598 11836018 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.25 | 17994277 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.75 | 10783313 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.13 | 17255318 |
MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.30 | 17553498 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.33 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.33 | 17551590 15992940 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.89 | 15604871 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.10 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
4.93 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
4.93 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
5.82 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
5.82 | 12371664 |
MESH:D007859 |
Learning Disorders |
|
Cholesterol |
4.58 | 17134702 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
4.07 | 18555241 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Ketoconazole |
4.26 | 1311351 2166429 8889330 19744259 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Ketoconazole |
4.13 | 11332679 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
8.82 | 15070760 |
MESH:D007938 |
Leukemia |
|
Curcumin |
8.82 | 18462866 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
8.82 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
8.16 | 17077332 12560223 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
8.16 | 16106398 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
16.58 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
16.58 | 16972261 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
U 0126 |
16.58 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.02 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
7.87 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
7.87 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
5.37 | 16467208 19850784 17050201 16968895 20471514 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
5.37 | 17596541 16294345 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
5.37 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
10.66 | 9834237 17107899 16330433 16823087 15622746 16112521 17869043 19642359 15748426 17649720 15336539 19035177 12679006 15213294 17712046 16891316 17217047 11468182 16331271 19075265 12712474 16966277 19225113 12018890 11161223 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
10.66 | 16087638 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
10.66 | 17294898 17506722 19642359 17107899 17712046 12679006 16891316 16140955 16935935 19029980 16823087 17217047 17301526 17339181 9834237 16766008 19075265 19225113 16788101 16331271 19035177 15748426 17649720 17368321 17361223 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
10.01 | 16882451 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
10.01 | 16106398 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.16 | 15821434 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
4.69 | 8812269 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
2.91 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Ketoconazole |
4.18 | 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
5.58 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
5.58 | 19638242 20032147 18407596 18522880 18665156 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
cis-9, trans-11-conjugated linoleic acid |
7.60 | 17869086 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
7.60 | 18705752 17355460 18006644 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
7.60 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
7.60 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
7.60 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
7.60 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
3.71 | 16956363 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.71 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
33.13 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
33.13 | 18177683 15890375 9163691 2125692 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
33.13 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
33.13 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Butylated Hydroxytoluene |
33.13 | 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
ciprofibrate |
33.13 | 12771043 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
33.13 | 10737359 20434301 21278145 18978307 19426721 19642983 18644402 15175105 20492335 2422723 19638242 21071580 20452335 19073162 18754104 18648771 19499222 20118626 19812893 19551842 20405173 19850985 20137499 19254457 12771043 19255062 21047994 19996281 12112319 9163691 19690152 16942905 19294768 21167192 20501860 20583210 18977376 2862719 15885732 19427195 19256749 20101389 19090486 19833225 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
33.13 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
33.13 | 19812893 20405173 19321006 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
33.13 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
33.13 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.90 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
14.90 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
14.90 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
14.90 | 18164116 18544905 2563599 3124819 19004024 19539802 18093689 16267830 17854601 18079962 18282651 17942915 19519916 19009564 16842330 18775883 18253720 9362446 18308698 17174075 19126423 21159647 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.90 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.94 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.80 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.71 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.49 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
15.94 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
15.94 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
15.94 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
15.94 | 18520028 20064080 17053015 18816296 18569708 20869020 20135361 6695378 20464547 |
MESH:D008175 |
Lung Neoplasms |
|
Butylated Hydroxytoluene |
15.94 | 16337739 18597497 19359593 15390079 11246140 19925653 11696405 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
15.94 | 18462866 19359593 16243823 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
15.94 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
15.94 | 20512841 6695378 20970405 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
15.94 | 19931552 16712894 17077188 17306315 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
15.94 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
3.20 | 18462866 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
3.80 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.43 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
4.17 | 16173963 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.71 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Butylated Hydroxytoluene |
5.40 | 1500032 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
5.40 | 11606380 8985016 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.55 | 17453147 |
MESH:D008545 |
Melanoma |
|
Curcumin |
6.31 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
resveratrol |
6.31 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
6.31 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
6.31 | 16752155 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
3.65 | 17263510 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.90 | 16940565 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.89 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.24 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.80 | 18765137 18803445 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.77 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
14.08 | 19417148 19549372 15949261 11468182 14977855 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
14.08 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
14.08 | 15744524 15867202 16118317 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
14.08 | 17935668 16490592 16267019 17049120 17164350 14749477 |
MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
4.71 | 18160304 10890648 12130978 15259001 15834315 15213630 10479408 12879239 15241586 17724436 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
10.63 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
10.63 | 17962980 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.54 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.12 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
14.88 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
14.88 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
14.88 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
14.88 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
2.79 | 17188708 17015251 17125593 16317513 16525036 16456233 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
7.58 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
7.58 | 12213967 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.22 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.33 | 7678174 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
8.63 | 16624393 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
8.63 | 18495463 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.33 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
9.50 | 16946489 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
9.50 | 11141357 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
9.50 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
9.50 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
7.49 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
7.49 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
3.99 | 12497104 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.89 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.83 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
13.42 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
13.42 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
13.42 | 9125849 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
5.08 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
14.33 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
14.33 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
14.33 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
14.33 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.06 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
7.06 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
3.90 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.57 | 20387270 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Cholesterol |
17.23 | 9802331 20557099 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
Clofibrate |
17.23 | 9802331 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
17.23 | 9802331 |
MESH:D009765 |
Obesity |
|
Curcumin |
4.23 | 19297423 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.23 | 21332399 18457598 17217161 20518802 11836018 20132043 18674790 16723640 19632207 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
2.97 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
3.13 | 18719352 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
3.76 | 17513867 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.45 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
12.84 | 19769630 12452020 16624393 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
12.84 | 19020741 18462866 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
12.84 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
12.84 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
U 0126 |
12.84 | 16211241 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.48 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
10.49 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
10.49 | 17440100 19196508 19401701 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
10.49 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
10.49 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.19 | 11578682 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.66 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Cholesterol, Dietary |
3.95 | 19014385 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.70 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Zymosan |
4.36 | 19088179 18977430 17371808 15979727 18557954 14761945 19641140 18760300 15259001 11985352 17826846 |
MESH:D011014 |
Pneumonia |
|
Butylated Hydroxytoluene |
9.60 | 11893704 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
9.60 | 12224865 11605937 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.45 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.05 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
7.43 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
7.43 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.22 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
24.78 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
24.78 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
24.78 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
24.78 | 11896295 11118676 11399792 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
24.78 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
3.72 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.00 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.00 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.00 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
2.00 | 11398177 18769126 18156803 10851300 18226269 12497104 15129424 |
MESH:D011471 |
Prostatic Neoplasms |
|
Ketoconazole |
2.00 | 17404083 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.00 | 17636462 15767336 17804756 16731767 17675339 17718901 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.00 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.11 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.78 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
3.99 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.02 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.25 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.25 | 10548101 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
4.06 | 19168576 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.03 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
2.99 | 16314181 17058453 15827377 16317513 17520802 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
7.66 | 10666014 18379247 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
7.66 | 18379247 11700416 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.36 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.33 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
9.21 | 16116481 16283617 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
9.21 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
3.65 | 18462866 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.45 | 16646077 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
1.99 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
4.71 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
4.71 | 17978042 14763951 15475178 16876388 11044598 3137016 11738929 1511512 |
MESH:D018805 |
Sepsis |
|
Curcumin |
8.22 | 18389075 |
MESH:D018805 |
Sepsis |
|
Zymosan |
8.22 | 11441115 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
14.94 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
14.94 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
14.94 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
14.94 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
14.94 | 16467112 |
MESH:D019082 |
Smith-Lemli-Opitz Syndrome |
|
24-hydroxycholesterol |
6.01 | 11254748 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.39 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
8.15 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
8.15 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
3.99 | 12833885 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.79 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
4.13 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.13 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.13 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.13 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
5.97 | 19188055 16631530 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
5.97 | 15138204 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.01 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.45 | 16045194 16684133 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.70 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.12 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.70 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.35 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
9.58 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
9.58 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
9.58 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
8.35 | 16227395 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
8.35 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.43 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.68 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.88 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
3.98 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
13.23 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
13.23 | 12845720 20435036 12973940 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
13.23 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
13.23 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
13.23 | 17306315 16452187 11723127 16712894 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.12 | 8888407 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.73 | 18462866 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
3.78 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
13.18 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
13.18 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
13.18 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.46 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
7.81 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
7.81 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.06 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
17.13 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
17.13 | 1336536 |
MESH:D014605 |
Uveitis |
|
Zymosan |
17.13 | 11006244 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.89 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.05 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.06 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.78 | 17488730 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.55 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.70 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.28 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.51 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.89 | 17120751 |